Published: Jan, 2018
The global insulin delivery devices market features a largely fragmented vendor landscape, according to a recent report by Transparency Market Research. The intense level of competition in the market owing to the presence of several international and local players has compelled vendors to introduce products with competitive pricing and differentiating features. The focus on strategic alliances, collaborations with the constantly rising numbers of diabetes clinics, and aggressive marketing practices has increased in the recent years.
The report states that the market will exhibit a promising 8.6% CAGR from 2017 to 2025, rising to a valuation of US$20.9 bn by the end of 2025 from US$10.2 bn in 2016.
Insulin Pens to Remain Most In-demand Product Variety
Geographically, the market in North America held the top spot in the global insulin delivery devices market, acquiring a nearly 37% of the overall demand in 2016. The high prevalence of the condition in the U.S. and the high rate of adoption of advanced mechanisms are expected to help the region maintain its spot over the forecast period as well. In terms of the variety of insulin delivery devices available in the market, the segment of insulin pen accounted for the dominant 42% share of overall global demand in the said year.
Rising Global Burden of Diabetes to have High Impact on Market Growth
The rapidly spreading epidemic of diabetes across the globe has kept the interest level in diabetes-related R&D immensely high in the recent years. Despite the condition affecting millions of people worldwide, scientists and researchers have not been able to find a cure for the disease and controlling it by the effective and timely administration of insulin remains an indispensable measure for patients with type-1 diabetes to lead a normal life.
Thus in the absence of a complete and effective cure for diabetes, the emphasis largely lies on making insulin therapy better and more successful As a result, the continuous quest for new and pioneering therapies and insulin delivery measures continues and is reflecting positively on the overall global market for insulin delivery devices. The market also benefits massively from the constant rise in the number of vendors, R&D activities, technological advancements in products, and easy availability of advanced products across the globe. Moreover, favorable reimbursement scenario in developed nations and a constant rise in awareness programs across developing economies are also working in favor of the market.
Positive Development of Safety Needles to have High Impact on Growth Prospects
Although the market displays mostly positive growth prospects, a handful of factors could hinder its expansion as expected. One of the key challenges facing the market is the lack of encouraging medical reimbursement policies in several emerging economies. With a rapidly rising pool of diabetics in emerging countries across regions such as Asia Pacific and Latin America, the lack of encouraging reimbursement scenario could act as a big blow for international firms wanting to exploit the massive growth opportunities.
Additionally, needle anxiety among patients and the positive pace of development of oral insulin, which could act as an effective alternative to IV and subcutaneous insulin could hamper the market to a certain extent. Nevertheless, promising developments in the area of safety needles and a rise in diabetes-related expenditure and R&D activities in a number of countries could open up favorable growth avenues for companies operating in the market for insulin delivery devices.
This assessment of the global insulin delivery devices market is based on a recent market research report by Transparency Market Research, titled “Insulin Delivery Devices Market (Product Type - Insulin Syringe, Insulin Pens, and Insulin Pumps; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Sales, and Diabetes Clinics and Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025.”
For the study, the market has been segmented as follows:
Insulin Delivery Devices Market, by Product Type
- Insulin syringe
- Insulin Pens
- Disposable Pens
- Reusable Pens
- Pen Needles
- Insulin Pumps
- Tethered Insulin Pumps
- Disposable/Patch Insulin Pumps
- Others (insulin Patches & Needle Free Injection Jet)
Insulin Delivery Devices Market, by Distribution Channels
- Hospital Pharmacy
- Retail Pharmacy
- Online Sales
- Diabetes Clinics/ Centers
Insulin Delivery Devices Market, by Geography
- North America
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact